Effectiveness of sacituzumab govitecan in metastatic triple-negative breast cancer: a real-world retrospective cohort study from Central Europe.

Oncologist · 2026 · PMC12923110 · PMID 41578063

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.2000

boldest claim

The sentences

a numerical trendP = .06so close (0.05 < p ≤ 0.1)

Similarly, the number of prior palliative treatment lines did not significantly affect PFS, although a numerical trend was observed (HR = 1.11, 95% CI 1.0-1.23; P = .06).

also in 728 other papers

near-significantP < .20not close (p > 0.1)

Variables that showed a significant or near-significant association ( P < .20) with the dependent variable were included in the multivariate model, based on the authors’ previous analytical experience.

also in 1,659 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.